36848 Federal Register / Vol. 87, No. 118 / Tuesday, June 21, 2022 / Notices 

1Burden is defined as the total time, effort, or 

financial resources expended by persons to 

generate, maintain, retain, or disclose or provide 

information to or for a federal agency. For further 

explanation of what is included in the information 

collection burden, refer to 5 CFR 1320.3. 

2Annual public reporting burden based on 

respondents over the last three-year period. 3The estimates for cost per response are derived 

using the formula: Average Burden Hours per 

Response * 87.00 per hour = Average Cost per 

Response. The hourly cost figure comes from the 

FERC average salary plus benefits of $180,703 per 

year (or $87.00/hour). These estimates were 

updated in May 2021. This figure is being used 

because the staff thinks industry is similarly 

situated in terms of average hourly cost. 

requirements. The consequences of not 

collecting this information are that the 

Commission would be unable to fulfill 

its statutory mandate under the Energy 

Policy Act of 2005 to: 

• Establish a schedule for agencies to 

review requests for federal 

authorizations required for a project, 

and 

• Compile a record of each agency’s 

decision, together with the record of the 

Commission’s decision, to serve as a 

consolidated record for the purpose of 

appeal or review, including judicial 

review. 

Type of Respondent: Agencies with 

federal authorization responsibilities. 

Estimate of Annual Burden: 1 The 

Commission estimates the annual public 

reporting burden 2 and cost 3 (rounded) 

for the information collection as 

follows: 

FERC–606 (NOTIFICATION OF REQUEST FOR FEDERAL AUTHORIZATION AND REQUESTS FOR FURTHER INFORMATION), AND

FERC–607 (REPORT ON DECISION OR ACTION ON REQUEST FOR FEDERAL AUTHORIZATION) 

Number of 

respondents 

Annual 

number of 

responses per 

respondent 

Total 

number of 

responses 

Average 

burden hours & 

cost per response 

Total annual 

burden hours & 

total annual cost 

Cost per 

respondent 

($) 

(1) (2) (1) * (2) = (3) (4) (3) * (4) = (5) (5) ÷ (1) 

FERC–606 ............................................... 1 1 1 4 hrs.; $348 ................ 4 hrs.; $348 ................ $348 

FERC–607 ............................................... 1 1 1 1 hr.; $87 .................... 1 hr.; $87 .................... 87 

Total ................................................. 2 .......................... 2 ..................................... 5 hrs.; $435 ................ ........................

Comments: Comments are invited on: 

(1) whether the collection of 

information is necessary for the proper 

performance of the functions of the 

Commission, including whether the 

information will have practical utility; 

(2) the accuracy of the agency’s estimate 

of the burden and cost of the collection 

of information, including the validity of 

the methodology and assumptions used; 

(3) ways to enhance the quality, utility 

and clarity of the information collection; 

and (4) ways to minimize the burden of 

the collection of information on those 

who are to respond, including the use 

of automated collection techniques or 

other forms of information technology. 

Dated: June 14, 2022. 

Debbie-Anne A. Reese, 

Deputy Secretary. 

[FR Doc. 2022–13220 Filed 6–17–22; 8:45 am] 

BILLING CODE 6717–01–P 

DEPARTMENT OF ENERGY 

Federal Energy Regulatory 

Commission 

Combined Notice of Filings 

Take notice that the Commission has 

received the following Natural Gas 

Pipeline Rate and Refund Report filings: 

Filings Instituting Proceedings 

Docket Numbers: RP22–979–000. 

Applicants: WBI Energy 

Transmission, Inc. 

Description: § 4(d) Rate Filing: 2022 

Negotiated and Non-Conforming SA 

Blue Flint to be effective 7/15/2022. 

Filed Date: 6/14/22. 

Accession Number: 20220614–5030. 

Comment Date: 5 p.m. ET 6/27/22. 

Any person desiring to intervene or 

protest in any of the above proceedings 

must file in accordance with Rules 211 

and 214 of the Commission’s 

Regulations (18 CFR 385.211 and 

385.214) on or before 5:00 p.m. Eastern 

time on the specified comment date. 

Protests may be considered, but 

intervention is necessary to become a 

party to the proceeding. 

The filings are accessible in the 

Commission’s eLibrary system (https://

elibrary.ferc.gov/idmws/search/ 

fercgensearch.asp) by querying the 

docket number. 

eFiling is encouraged. More detailed 

information relating to filing 

requirements, interventions, protests, 

service, and qualifying facilities filings 

can be found at: http://www.ferc.gov/ 

docs-filing/efiling/filing-req.pdf. For 

other information, call (866) 208–3676 

(toll free). For TTY, call (202) 502–8659. 

Dated: June 14, 2022. 

Debbie-Anne A. Reese, 

Deputy Secretary. 

[FR Doc. 2022–13221 Filed 6–17–22; 8:45 am] 

BILLING CODE 6717–01–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[FRL 9855–01–OW] 

Lifetime Drinking Water Health 

Advisories for Four Perfluoroalkyl 

Substances 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice of availability. 

SUMMARY: The Environmental Protection 

Agency (EPA) announces the release of 

health advisories for four perfluoroalkyl 

substances (PFAS), including interim 

updated lifetime drinking water health 

advisories for perfluorooctanoic acid 

(PFOA) and perfluorooctane sulfonic 

acid (PFOS), and final health advisories 

for hexafluoropropylene oxide (HFPO) 

dimer acid and its ammonium salt 

(together referred to as ‘‘GenX 

chemicals’’) and perfluorobutane 

sulfonic acid and its related compound 

potassium perfluorobutane sulfonate 

(together referred to as ‘‘PFBS’’). EPA’s 

health advisories, which identify the 

concentration of chemicals in drinking 

water at or below which adverse health 

effects are not anticipated to occur, are: 

0.004 parts per trillion (ppt) for PFOA, 

0.02 ppt for PFOS, 10 ppt for GenX 

chemicals, and 2,000 ppt for PFBS. 

Health advisories are non-regulatory 

and reflect EPA’s assessment of the best 

available peer-reviewed science. The 

interim updated health advisories for 

PFOA and PFOS supersede EPA’s 2016 

health advisories for PFOA and PFOS. 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 118 / Tuesday, June 21, 2022 / Notices 36849 

FOR FURTHER INFORMATION CONTACT: 

Susan Euling, Health and Ecological 

Criteria Division, Office of Water (Mail 

Code 4304T), Environmental Protection 

Agency, 1200 Pennsylvania Avenue 

NW, Washington, DC 20460; telephone: 

(202) 566–2717; or email: euling.susan@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. What are PFAS, and specifically, 

what are PFOA, PFOS, GenX 

chemicals, and PFBS? 

PFAS are a large and diverse 

structural family of compounds used in 

myriad commercial applications due to 

their unique properties, such as 

resistance to high and low temperatures, 

resistance to degradation, and nonstick 

characteristics. Although PFAS have 

been manufactured and used broadly in 

commerce since the 1940s, particular 

concern over potential adverse effects 

on human health grew in the early 

2000s with the discovery of PFOA and 

PFOS in human blood. Since that time, 

hundreds of PFAS have been identified 

in water, soil, and air. Many PFAS are 

environmentally persistent, 

bioaccumulative, and have long halflives in humans, particularly the longerchained carbon species such as PFOA 

and PFOS. Most uses of PFOA and 

PFOS were phased out by U.S. 

manufacturers in the mid-2000s 

although there are a limited number of 

ongoing uses. In addition, some 

currently used PFAS break down into 

PFOA and PFOS in the environment. 

PFAS with fewer carbon atoms, such as 

GenX chemicals and PFBS, were 

subsequently developed to replace 

PFOA and PFOS, respectively, and 

integrated into various consumer 

products and industrial applications 

because they have the desired properties 

and characteristics associated with this 

class of compounds but are more 

quickly eliminated from the human 

body than PFOA and PFOS. 

II. What health effects are associated 

with exposure to PFOA, PFOS, GenX 

chemicals, and PFBS? 

The interim updated health advisories 

for PFOA and PFOS are based on 

human epidemiology studies in 

populations exposed to these chemicals. 

Human studies have found associations 

between PFOA and/or PFOS exposure 

and effects on the immune system, the 

cardiovascular system, human 

development (e.g., decreased birth 

weight), and cancer. The most sensitive 

non-cancer effect and the basis for the 

interim updated health advisories for 

PFOA and PFOS is suppression of 

vaccine response (decreased serum 

antibody concentrations) in children. 

While there is evidence that PFOA is 

likely to be carcinogenic to humans, 

EPA has not derived a cancer risk 

concentration in water for PFOA at this 

time. There is suggestive evidence of 

carcinogenic potential of PFOS in 

humans. Cancer analyses are ongoing 

for both PFOA and PFOS. 

EPA’s final health advisories for GenX 

chemicals and PFBS are based on 

animal toxicity studies following oral 

exposure to these chemicals. GenX 

chemicals have been linked to health 

effects on the liver, the kidney, the 

immune system, and developmental 

effects, as well as cancer. The most 

sensitive non-cancer effect and the basis 

for the final health advisories for GenX 

chemicals is a liver effect (constellation 

of liver lesions). There is suggestive 

evidence of carcinogenic potential of 

oral exposure to GenX chemicals in 

humans, but data are insufficient to 

derive a cancer risk concentration in 

water for GenX chemicals at this time. 

Animal studies following oral exposure 

to PFBS have shown health effects on 

the thyroid, reproductive organs and 

tissues, developing fetus, and kidney 

following oral exposure. The most 

sensitive non-cancer effect and the basis 

for the final health advisory for PFBS is 

a thyroid effect (decreased serum total 

thyroxine). There are no known studies 

evaluating potential cancer effects of 

PFBS and so the potential for cancer 

effects after PFBS exposure could not be 

evaluated. 

III. What are drinking water health 

advisories? 

Under the Safe Drinking Water Act, 

EPA may publish health advisories for 

contaminants that are not subject to any 

national primary drinking water 

regulation. 42 U.S.C. 300g–1(b)(1)(F)). 

EPA develops health advisories to 

provide information on the chemical 

and physical properties, occurrence and 

exposure, health effects, quantification 

of toxicological effects, other regulatory 

standards, analytical methods, and 

treatment technology for drinking water 

contaminants. Health advisories 

describe concentrations of drinking 

water contaminants at which adverse 

health effects are not anticipated to 

occur over specific exposure durations 

(e.g., one-day, ten-days, and a lifetime). 

Health advisories serve as technical 

information to assist Federal, state and 

local officials, as well as managers of 

public or community water systems in 

protecting public health. They are not 

regulations and should not be construed 

as legally enforceable Federal standards. 

Health advisories may change as new 

information becomes available. 

IV. What are EPA’s interim health 

advisories for PFOA and PFOS? 

EPA is releasing interim updated 

health advisories for PFOA and PFOS 

based on data and draft analyses that 

indicate that the levels at which 

negative health effects could occur are 

much lower than previously understood 

when the agency issued its 2016 health 

advisories for PFOA and PFOS (70 parts 

per trillion or ppt). Human studies have 

found associations between PFOA and/ 

or PFOS exposure and effects on the 

immune system, the cardiovascular 

system, development (e.g., decreased 

birth weight), and cancer. These data 

and draft analyses, which were released 

publicly in November 2021, are 

currently undergoing EPA Science 

Advisory Board (SAB) review. EPA is 

concerned about the public health 

implications of these preliminary 

findings and is therefore issuing interim 

updated health advisories for PFOA and 

PFOS. The interim updated health 

advisories for PFOA and PFOS are 0.004 

ppt and 0.02 ppt, respectively. The 

interim updated health advisories 

replace the 2016 final health advisories 

for PFOA and PFOS which were both 

set at 70 ppt. EPA is reviewing and will 

respond to the SAB comments as the 

Agency moves forward to develop 

Maximum Contaminant Level Goals 

(MCLGs) to support the Safe Drinking 

Water Act National Primary Drinking 

Water Regulation for PFOA and PFOS, 

which is expected to be proposed later 

this year. 

V. What are EPA’s final health 

advisories for GenX chemicals and 

PFBS? 

EPA is also releasing final health 

advisories for GenX chemicals and 

PFBS for the first time, based on EPA’s 

2021 final toxicity assessments for these 

PFAS. In chemical and product 

manufacturing, GenX chemicals are 

considered a replacement for PFOA, and 

PFBS is considered a replacement for 

PFOS. Animal toxicity studies following 

oral exposure to GenX chemicals have 

reported health effects in the liver, 

kidney, immune system, development, 

as well as cancer. For PFBS, animal 

studies have reported health effects on 

the thyroid, reproductive system, 

development, and kidney following oral 

exposure. The final health advisories for 

GenX chemicals and PFBS are 10 ppt 

and 2,000 ppt, respectively. 

Radhika Fox, 

Assistant Administrator. 

[FR Doc. 2022–13158 Filed 6–17–22; 8:45 am] 

BILLING CODE 6560–50–P 


jspears on DSK121TN23PROD with NOTICES1